Prime Pharmatech (India) Limited
About Prime Pharmatech (India) Limited
Data last updated:
Prime Pharmatech (India) Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 May 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1991PLC012702. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.75 Cr and a paid-up capital of ₹1.75 Cr. It is led by directors including Prasant Kumar Mahapatra and Rajender Prashad Rathi.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 15 – 9 – 182/1 1st Floor Maharaj Gunj, Hyderabad, Telangana, India – 500012.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.07 Cr. For the same year it recorded a net profit of ₹1.19 Cr (net margin 38.8%) and EBITDA of ₹2.66 Cr (EBITDA margin 86.6%).
As per MCA filings, the company has open charges of ₹4.19 Cr on record. Court records list 14 cases involving the company, including 4 filed by the company and 10 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Prime Pharmatech (India) has one previous CIN (Corporate Identification Number): U24239AP1991PLC012702. The current CIN is U24239TG1991PLC012702, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1991PLC012702 | Current |
| U24239AP1991PLC012702 | Previous |
Contact details
Prime Pharmatech (India) Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address15 – 9 – 182/1 1st Floor Maharaj Gunj, Hyderabad, Telangana, India – 500012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Prime Pharmatech (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Prime Pharmatech (India) Limited
FY 2020 filings availablePrime Pharmatech (India) Limited reported revenue of ₹3.07 Cr for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹3.07 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.66 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.19 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 86.6% | ||
| Net Profit Margin | 38.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Prime Pharmatech (India) Limited, buy the company report.
Board of directors of Prime Pharmatech (India) Limited
Prime Pharmatech (India) has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasant Kumar Mahapatra | Director | 28 Jan 2017 | 9 Years 9 Months | Current |
| Rajender Prashad Rathi | Director | 13 May 1991 | 35 Years 5 Months | Current |
| Kedar Mal Sharma | Additional Director | 19 Feb 2018 | 8 Years 8 Months | Current |
Auditor
Prime Pharmatech (India) Limited is audited by GANESHAM & SRIDHAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GANESHAM & SRIDHAR | FY 2017 | 021898 |
Shareholding
The shareholding of Prime Pharmatech (India) Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Prime Pharmatech (India) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jan 2004 | 90341373 | Dewam Housing Finance Corporation Ltd. | ₹1.32 Lakh | Open | |
| 10 Sep 1998 | 90340128 | Statebank of Hyderabad | ₹90 Lakh | Open | |
| 14 Jun 1996 | 90340060 | Canara Bank | ₹70 Lakh | Open | |
| 27 May 1995 | 90338896 | Andhra Pradesh State Financial Corporation | ₹39.93 Lakh | Open | |
| 07 Oct 1994 | 90340002 | Canara Bank | ₹70 Lakh | Open |
To see the full charge records of Prime Pharmatech (India) Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Prime Pharmatech (India) Limited has 14 court cases on record: 4 filed by Prime Pharmatech (India), 10 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 0 |
| High courts | 6 | 3 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (CRLRP) | Filed against the company by The State of Telangana Rep by Drugs Inspector | Disposed |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by an individual | Disposed |
| High Court, ANDHRAPRADESH | Court case (CRLP) | Filed by the company against The State Rep. by the Drugs Inspector, Nellore | Disposed |
| High Court | Court case (CRLP) | Filed by the company against The State Rep. by the Drugs Inspector, Nellore | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Esi Corporation Rep. by T. Sambasiva Rao | Disposed |
To see the full case history of Prime Pharmatech (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prime Pharmatech (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prime Pharmatech (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Prime Pharmatech (India) Limited, buy the company report.
Recent activity
Prime Pharmatech (India) Limited has 8 board changes on record since 1991: 3 appointments and 5 cessations. The latest: Paras Agarwal ceased to be Additional Director on 05 Mar 2018.
8 earlier events are in the company report.
Frequently asked questions
Prime Pharmatech (India) is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 May 1991 (35+ years old) and is registered under CIN U24239TG1991PLC012702.
Prime Pharmatech (India) has 3 current directors:
- Prasant Kumar Mahapatra - Director
- Rajender Prashad Rathi - Director
- Kedar Mal Sharma - Additional Director
The latest financial statements of Prime Pharmatech (India) on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
No. Prime Pharmatech (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Prime Pharmatech (India) is U24239TG1991PLC012702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prime Pharmatech (India) has 14 court cases on record: 4 filed by the company and 10 filed against it. Most are in the district courts.
Prime Pharmatech (India) was incorporated on 13 May 1991, making it 35+ years old. It is registered with the Registrar of Companies, Hyderabad.
Paras Agarwal ceased to be Additional Director on 05 Mar 2018. Kedar Mal Sharma was appointed as Additional Director on 19 Feb 2018. Surya Sankara Reddy Guddeti ceased to be Director on 09 Jun 2017. Prime Pharmatech (India) has 8 board changes on record in total.
The registered office of Prime Pharmatech (India) is at 15 – 9 – 1821 1st Floor Maharaj Gunj, Hyderabad, Telangana, India – 500012.
Prime Pharmatech (India) operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
